Vaccine

UK scientists are developing a vaccine for the current Ebola outbreak in the Democratic Republic of Congo, with clinical trials expected to begin within months. The outbreak involves the rare Bundibugyo species of Ebola, which kills approximately one-third of those infected and has no approved vaccine. The WHO has upgraded its risk assessment, saying the outbreak is “spreading rapidly.” In eastern DR Congo, angry crowds burned medical tents after being prevented from burying the body of a suspected Ebola victim, highlighting community resistance to containment measures. ...

The World Health Organization (WHO) has warned that a vaccine for the current Ebola outbreak could take up to nine months to develop, as the death toll continues to rise. The Washington Post previously reported that the White House had resisted letting an Ebola-infected doctor return to the US for treatment, sparking controversy. The outbreak is primarily spreading across African regions, with the international community ramping up aid efforts. Sources: BBC, Washington Post ...

[Flash] Moderna Stock Surges 14% on Hantavirus Vaccine Prospect Moderna (MRNA) shares jumped 14% as investors reacted positively to the company’s hantavirus vaccine development. The surge comes amid global attention on the hantavirus cruise ship outbreak, with investors optimistic about the vaccine’s commercial potential. Analysts advise monitoring clinical trial progress. Source: Google News